menu
    • menu

    Company profile for Acumen Pharmaceuticals

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are at a breakthrough moment for Alzheimer’s disease research and drug development. At Acumen, we are leveraging decades of learnings to deliver treatments that can truly impact everyone affected by this devastating disease.Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomer...
    We are at a breakthrough moment for Alzheimer’s disease research and drug development. At Acumen, we are leveraging decades of learnings to deliver treatments that can truly impact everyone affected by this devastating disease.Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Aβo) in synaptic dysfunction and neurodegeneration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acumen PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    427 Park St. Charlottesville, VA 22902
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acumenpharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acumen-pharm/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/acumenpharm

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acumen Pharma Discloses 2025 Financials And Business Highlights
    Acumen Pharma Discloses 2025 Financials And Business Highlights

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262856/0/en/Acumen-Pharmaceuticals-Reports-Financial-Results-for-the-Year-Ended-December-31-2025-and-Business-Highlights.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Acumen Pharma To Release Q4 2025 Financials On March 26, 2026
    Acumen Pharma To Release Q4 2025 Financials On March 26, 2026

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259413/0/en/Acumen-Pharmaceuticals-to-Report-Fourth-Quarter-and-Year-End-2025-Financial-Results-on-March-26-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Acumen Pharma Presents Studies on Enhanced Brain Delivery
    Acumen Pharma Presents Studies on Enhanced Brain Delivery

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257081/0/en/Acumen-Pharmaceuticals-Presents-Studies-on-Enhanced-Brain-Delivery-Biomarker-Research-and-Novel-Antibodies-at-Advances-in-Alzheimer-s-Treatment-at-International-Conference-on-Alzhe.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Acumen Pharma Raises $35.75M for Brain Delivery Molecules
    Acumen Pharma Raises $35.75M for Brain Delivery Molecules

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256089/0/en/Acumen-Pharmaceuticals-Announces-35-75-Million-Private-Placement-to-Advance-Potential-Best-in-Class-Molecules-from-Amyloid-Beta-Oligomer-Selective-Enhanced-Brain-Delivery-Portfolio.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Acumen Pharma Joins Stifel 2026 Virtual CNS Forum
    Acumen Pharma Joins Stifel 2026 Virtual CNS Forum

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3253291/0/en/Acumen-Pharmaceuticals-to-Participate-in-the-Stifel-2026-Virtual-CNS-Forum.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Acumen Pharma Highlights Alzheimer's Treatment Progress
    Acumen Pharma Highlights Alzheimer's Treatment Progress

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248304/0/en/Acumen-Pharmaceuticals-to-Showcase-Advances-in-Alzheimer-s-Treatment-at-International-Conference-on-Alzheimer-s-and-Parkinson-s-Diseases-2026.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search